Single determination of plasma ACTH using an immunoradiometric assay with high detectability differentiates between

M Klose1, A Kofoed-Enevoldsen, L Ostergaard Kristensen

  • 1Department of Internal Medicine and Endocrinology, Herlev University Hospital, Denmark.

Insights

A single adrenocorticotropic hormone (ACTH) measurement effectively distinguishes ACTH-dependent from ACTH-independent Cushing's syndrome. This simple test aids in diagnosing the specific cause of Cushing's syndrome.

Area of Science:

  • Endocrinology
  • Clinical Diagnostics
  • Hormone Assays

Background:

  • Cushing's syndrome results from prolonged exposure to excess cortisol.
  • Differentiating between ACTH-dependent and ACTH-independent causes is crucial for appropriate treatment.
  • Accurate diagnostic tools are essential for patient management.

Purpose of the Study:

  • To evaluate the diagnostic utility of a highly sensitive ACTH assay.
  • To determine if a single ACTH measurement can differentiate ACTH-dependent from ACTH-independent Cushing's syndrome.
  • To compare the effectiveness of ACTH measurements with corticotropin-releasing hormone (CRH) tests.

Main Methods:

  • Retrospective analysis of 56 Cushing's syndrome patient records.
  • Measurement of basal morning plasma 1-39 ACTH using an immunoradiometric assay (IRMA).
  • Performance of peripheral corticotropin-releasing hormone (CRH) tests in a subset of patients.

Main Results:

  • A single ACTH measurement with a cut-off of 2.4 pmol/L completely separated the two groups.
  • Mean ACTH levels were significantly higher in ACTH-dependent (14.4 pmol/L) versus ACTH-independent (0.6 pmol/L) Cushing's syndrome.
  • Repeated ACTH measurements or CRH stimulation further increased separation but were not superior to single measurements in most cases.

Conclusions:

  • A single basal morning ACTH determination is generally sufficient to differentiate ACTH-dependent and ACTH-independent Cushing's syndrome.
  • Repeated ACTH measurements may be necessary for borderline cases (ACTH 2-3 pmol/L).
  • The peripheral CRH test did not offer advantages over repeated ACTH measurements for diagnosis.